Furthermore, high levels of TSPAN3 positively correlated with poor differentiation, lymph node involvement, advanced pathological tumor-metastasis-node stage, and poor prognosis among patients with NSCLC. Here, TSPAN3 is linked to non-small cell lung carcinoma.